Skip to main content
. Author manuscript; available in PMC: 2017 Mar 28.
Published in final edited form as: Cancer Lett. 2016 Jan 18;372(2):179–186. doi: 10.1016/j.canlet.2016.01.018

Fig. 4.

Fig. 4

Pharmacokinetic analysis of entrectinib treated tumors. Representative graph indicating peak plasma concentrations (ng/mL) at about 6 hr post administration of the drug. After the final dose (60 mg/kg BID) was given, the blood samples were drawn from 4 mice per time point via retro-orbital bleeding, collected in heparinized tubes on wet ice, and plasma concentrations were measured as described in methods.